From: Survival benefits of adding simvastatin to standard therapy for secondary prevention of bleeding esophageal varices in patients with hepatitis C-related liver cirrhosis
Multivariate
OR (95% CI)
p-value
Encephalopathy
0.725 (0.352–1.652)
0.998
Survival
0.136 (0.020–0.916)
0.040*
Myalgia
5.812 (0.658–51.361)
0.113
Child score
4.419 (0.874–22.341)
0.072